Lv44
688 积分 2025-08-07 加入
TRI-611, a selective, brain-penetrant molecular glue degrader of ALK
3天前
已完结
Hijacking ERAD for targeted degradation of transmembrane proteins
1个月前
已完结
Hijacking ERAD for targeted degradation of transmembrane proteins
1个月前
已完结
Discovery of (S)-6-methoxy-chroman-3-carboxylic acid (4-pyridin-4-yl-phenyl)-amide as potent and isoform selective ROCK2 inhibitors
2个月前
已完结
Rational Design of 6‐Amino‐2‐Piperazinylpyridine‐Based ROCK2 Inhibitors With Anti‐Breast Cancer Metastatic Efficiency
2个月前
已完结
Rational Design of 6‐Amino‐2‐Piperazinylpyridine‐Based ROCK2 Inhibitors With Anti‐Breast Cancer Metastatic Efficiency
2个月前
已完结
Design and optimization strategies of PROTACs and its Application, Comparisons to other targeted protein degradation for multiple oncology therapies
2个月前
已完结
ROCK-2-selective targeting and its therapeutic outcomes
2个月前
已完结
Rho/ROCK Pathway as a Therapeutic Target in Multiple Diseases
2个月前
已完结
Complete biosynthesis of the anticancer cephalotaxinone and homoerythratine
2个月前
已完结